alendronate has been researched along with fluorides in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Balena, R; Battle, MA; Hayes, WC; Klein, H; Lafage, MH; Rodan, GA; Seedor, JG; Shea, M | 1 |
| Bellantoni, MF | 1 |
| Seeman, E | 1 |
| Fallon, JJ; Goldstein, MF; Harning, R | 1 |
| Halbekath, J | 1 |
| Aldini, NN; Carpi, A; Fini, M; Giardino, R; Giavaresi, G; Gnudi, S; Rocca, M | 1 |
| Ringe, JD; Rovati, LC | 1 |
| Bilezikian, JP; Rubin, MR | 1 |
| Sone, T | 1 |
| Chou, MY; Everett, ET; Jafarov, T; Yan, D | 1 |
| Baba, H; Fujibayashi, Y; Kawahara, H; Kobayashi, S; Miyazaki, T; Nakajima, H; Okazawa, H; Tsuchida, T; Uchida, K; Yayama, T | 1 |
| Adachi, JD; Cheung, AM; Cranney, A; Crilly, R; Gafni, A; Ismaila, N; Josse, RG; Kastner, M; Papaioannou, A; Sawka, AM; Thabane, L; Woodhouse, LJ | 1 |
| Itai, K; Muro-oka, G; Sato, H; Tanno, K | 1 |
| Graham, B; Hübner, R; Joshi, T; Kubeil, M; Nsubuga, A; Sgarzi, M; Stephan, H; Steudtner, R; Zarschler, K | 1 |
| Černič, T; Gyergyek, S; Horák, D; Kostiv, U; Lisjak, D; Majaron, B; Ponikvar-Svet, M; Vozlič, M | 1 |
8 review(s) available for alendronate and fluorides
| Article | Year |
|---|---|
Osteoporosis prevention and treatment.
Topics: Absorptiometry, Photon; Alendronate; Calcitonin; Diphosphonates; Exercise; Female; Fluorides; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Risk Factors; Vitamin D | 1996 |
Osteoporosis: trials and tribulations.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Calcitonin; Calcium, Dietary; Estrogen Replacement Therapy; Etidronic Acid; Female; Fluorides; Fractures, Bone; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Vitamin D | 1997 |
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Remodeling; Calcitonin; Clodronic Acid; Etidronic Acid; Fluorides; Glucocorticoids; Hormone Replacement Therapy; Humans; Lung Diseases, Obstructive; Osteoporosis; Prednisone; Time Factors | 1999 |
[Drug treatment for the treatment of primary osteoporosis].
Topics: Alendronate; Fluorides; Fractures, Bone; Humans; Osteoporosis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D | 2000 |
Treatment of osteoporosis in men with fluoride alone or in combination with bisphosphonates.
Topics: Alendronate; Bone and Bones; Bone Density; Climacteric; Drug Therapy, Combination; Etidronic Acid; Fluorides; Humans; Male; Osteoporosis; Pilot Projects | 2001 |
New anabolic therapies in osteoporosis.
Topics: Alendronate; Bone and Bones; Bone Resorption; Drug Therapy, Combination; Female; Fluorides; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Osteogenesis; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium | 2002 |
[Increase in bone mineral density and its effect on fracture risk].
Topics: Alendronate; Bone Density; Bone Remodeling; Fluorides; Fractures, Bone; Humans; Meta-Analysis as Topic; Osteoporosis; Parathyroid Hormone; Randomized Controlled Trials as Topic; Risk; Vitamin D | 2005 |
A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.
Topics: Aged; Alendronate; Exercise; Fluorides; Hip Fractures; Humans; Long-Term Care; Nursing Homes; Randomized Controlled Trials as Topic; Risk; Sunlight; Vitamin D | 2010 |
1 trial(s) available for alendronate and fluorides
| Article | Year |
|---|---|
Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
Topics: Aged; Alendronate; Biomarkers; Bone and Bones; Bone Density; Female; Fluorides; Fluorine Radioisotopes; Glucocorticoids; Humans; Middle Aged; Osteoporosis; Positron-Emission Tomography; Postmenopause; Prospective Studies | 2009 |
6 other study(ies) available for alendronate and fluorides
| Article | Year |
|---|---|
Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.
Topics: Alendronate; Analysis of Variance; Animals; Bone and Bones; Bone Development; Diphosphonates; Female; Fluorides; Ilium; Regression Analysis; Sodium Fluoride; Spine; Swine; Swine, Miniature; Tibia; Time Factors | 1995 |
Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.
Topics: Absorptiometry, Photon; Alendronate; Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Density; Calcitonin; Eating; Female; Fluorides; Ovariectomy; Phosphates; Rats; Rats, Sprague-Dawley | 2001 |
Modulation of murine bone marrow-derived CFU-F and CFU-OB by in vivo bisphosphonate and fluoride treatments.
Topics: Alendronate; Alkaline Phosphatase; Animals; Bone Density Conservation Agents; Bone Marrow Cells; Coloring Agents; Drug Combinations; Fibroblasts; Fluorides; Injections, Subcutaneous; Male; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred Strains; Osteoblasts; Random Allocation; Stem Cells | 2009 |
Serum ionic fluoride concentrations are significantly decreased after treatment with alendronate in patients with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Fluorides; Humans; Ion-Selective Electrodes; Middle Aged; Osteoporosis | 2011 |
Facile preparation of multifunctionalisable 'stealth' upconverting nanoparticles for biomedical applications.
Topics: Alendronate; Amines; Biomedical Engineering; Fluorides; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ligands; Luminescence; Nanoparticles; Nanotechnology; Polyethylene Glycols; Serum; Surface Properties; Tyrosine; Water; Yttrium | 2018 |
Formation of phosphonate coatings for improved chemical stability of upconverting nanoparticles under physiological conditions.
Topics: Alendronate; Fluorescence; Fluorides; Hydrogen-Ion Concentration; Nanoparticles; Organophosphonates; Solubility; Surface Properties; Temperature; Ultrasonic Waves; Yttrium | 2021 |